BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 17565855)

  • 1. [Study of bladder cancer gene and relevant molecular biology should be strengthened].
    Li CL; Han SJ
    Zhonghua Yi Xue Za Zhi; 2007 Mar; 87(12):793-4. PubMed ID: 17565855
    [No Abstract]   [Full Text] [Related]  

  • 2. Bladder cancer subtypes defined by genomic alterations.
    Knowles MA
    Scand J Urol Nephrol Suppl; 2008 Sep; (218):116-30. PubMed ID: 18815926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hereditary bladder cancer.
    Kiemeney LA
    Scand J Urol Nephrol Suppl; 2008 Sep; (218):110-5. PubMed ID: 18815925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Non-invasive molecular detection of bladder cancer].
    Hatachmi S
    Harefuah; 2009 Jan; 148(1):66-9, 86. PubMed ID: 19320394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic epidemiology of bladder cancer: scaling up in the identification of low-penetrance genetic markers of bladder cancer risk and progression.
    Malats N
    Scand J Urol Nephrol Suppl; 2008 Sep; (218):131-40. PubMed ID: 18815927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Gene mutation in bladder cancer. Towards molecular pathology].
    Olsen S
    Ugeskr Laeger; 1993 May; 155(21):1648-9. PubMed ID: 8317005
    [No Abstract]   [Full Text] [Related]  

  • 7. Molecular markers for detection, surveillance and prognostication of bladder cancer.
    Vrooman OP; Witjes JA
    Int J Urol; 2009 Mar; 16(3):234-43. PubMed ID: 19298346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Introduction to the molecular biology of cancer: translation to the clinic.
    Ruddon RW
    Prog Mol Biol Transl Sci; 2010; 95():1-8. PubMed ID: 21075326
    [No Abstract]   [Full Text] [Related]  

  • 9. Bladder carcinogenesis, in search of clues and genes.
    Bangma C; Jenster G
    Eur Urol; 2006 Aug; 50(2):205-7. PubMed ID: 16530924
    [No Abstract]   [Full Text] [Related]  

  • 10. New breast cancer genes-discovery at the intersection of complex data sets.
    Nevins JR
    Cancer Cell; 2007 Dec; 12(6):497-9. PubMed ID: 18068627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Molecular biology advances and perspectives in urology].
    Feria Bernal G; Arroyo KuribreƱa JC
    Rev Invest Clin; 2003; 55(2):243-7. PubMed ID: 12827935
    [No Abstract]   [Full Text] [Related]  

  • 12. Profiling of genetic variations in inflammation pathway genes in relation to bladder cancer predisposition.
    Yang H; Gu J; Lin X; Grossman HB; Ye Y; Dinney CP; Wu X
    Clin Cancer Res; 2008 Apr; 14(7):2236-44. PubMed ID: 18381966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Bladder cancer: understanding the disease and future implications for assessment and therapy].
    Droller M
    Rev Med Suisse; 2006 Dec; 2(90):2776-8, 2781-2, 2784. PubMed ID: 17225686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of RAS family genes in urothelial carcinoma.
    Boulalas I; Zaravinos A; Karyotis I; Delakas D; Spandidos DA
    J Urol; 2009 May; 181(5):2312-9. PubMed ID: 19303097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic variants in cell cycle control pathway confer susceptibility to bladder cancer.
    Ye Y; Yang H; Grossman HB; Dinney C; Wu X; Gu J
    Cancer; 2008 Jun; 112(11):2467-74. PubMed ID: 18361427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic susceptibility to bladder cancer with an emphasis on gene-gene and gene-environmental interactions.
    Horikawa Y; Gu J; Wu X
    Curr Opin Urol; 2008 Sep; 18(5):493-8. PubMed ID: 18670273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic variants in the death receptor 4 gene contribute to susceptibility to bladder cancer.
    Wang M; Wang M; Cheng G; Zhang Z; Fu G; Zhang Z
    Mutat Res; 2009 Feb; 661(1-2):85-92. PubMed ID: 19070628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular alterations associated with bladder cancer initiation and progression.
    Cordon-Cardo C
    Scand J Urol Nephrol Suppl; 2008 Sep; (218):154-65. PubMed ID: 18815930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving strategies for detecting genetic patterns of disease susceptibility in association studies.
    Calle ML; Urrea V; Vellalta G; Malats N; Steen KV
    Stat Med; 2008 Dec; 27(30):6532-46. PubMed ID: 18837071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of potential target genes of the 6p22.3-amplicon in urinary bladder cancer].
    Oeggerli M; Schraml P; Novotny H; Sauter G; Simon R
    Verh Dtsch Ges Pathol; 2005; 89():219-24. PubMed ID: 18035695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.